Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

High-Risk Neuroblastoma Chemotherapy Without G-CSF

NCT02786719

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Rady Children's Hospital San Diego, California, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

NCT00062491

Conditions: Melanoma, Neoplasm, Neoplasms, +10 more
Locations: For Information call 210-614-1701 for a site near you Tampa, Florida, United States

View Trial Details

Completed

Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

NCT01970540

Conditions: Endometrial Adenocarcinomas, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Hospital Universitari Vall D'Hebron Barcelona, Spain

Centro Oncológico Md Anderson International España Madrid, Spain

Hospital Ramón Y Cajal Madrid, Spain

Hospital Universitario Fundación Jiménez Madrid, Spain

View Trial Details

Completed

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

NCT04296149

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Chiara Maria Grana Milan, Italy

View Trial Details

Completed

Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas

NCT02978261

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Beijing Shijitan Hospital,CMU Beijing, Beijing Municipality, China

View Trial Details

Completed

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

NCT01449279

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

NCT00912418

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

NCT02100930

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

NCT00625846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +29 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View all 22 locations

View Trial Details

Completed

ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

Northwestern University Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions